References
- Howard JP, Jones D, Mills P, Marley R, Wragg A. Recurrent ascites due to constrictive pericarditis. Frontline Gastroenterol 2012; 3(4): 233–7.
- Tomoda Y, Kometani T, Kato S, Tanaka K. Immunoglobulin G4-related pericarditis. Eur Heart J 2019; 40(46): 3803.
- Umehara H, Okazaki K, Kawa S, Takahashi H, Goto H, Matsui S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol 2021; 31(3): 529–33.
- Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015; 36(42): 2921–64.
- Leya FS, Arab D, Joyal D, Shioura KM, Lewis BE, Steen LH, et al. The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. J Am Coll Cardiol 2005; 45(11): 1900–2.
- Parakh N, Mehrotra S, Seth S, Ramakrishnan S, Kothari SS, Bhargava B, et al. NT pro B type natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy. Indian Heart J 2015; 67(1): 40–4.
- Doumen M, Vankelecom B, Westhovens R, Michiels S. Pericarditis as a manifestation of IgG4-related disease. Rheumatol Int 2022; 42(7): 1287–95.
- Yuriditsky E, Dwivedi A, Narula N, Axel L, Horowitz JM, Vaynblat M. Constrictive pericarditis caused by IgG4-related disease requiring pericardiectomy after partial response to corticosteroids. JACC: Case Reports 2020; 2(10): 1558–63.
- Satou A, Notohara K, Zen Y, Nakamura S, Yoshino T, Okazaki K, et al. Clinicopathological differential diagnosis of IgG4-related disease: A historical overview and a proposal of the criteria for excluding mimickers of IgG4-related disease. Pathol Int 2020; 70(7): 391–402.
- Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 2015; 67(7): 1688–99.